Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma

Cancer. 2019 Nov 1;125(21):3692-3698. doi: 10.1002/cncr.32411. Epub 2019 Sep 10.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Retroviral Agents / therapeutic use*
  • Antigens, CD19 / immunology*
  • Antigens, CD19 / therapeutic use*
  • Antiretroviral Therapy, Highly Active
  • Biological Products
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Humans
  • Immunotherapy, Adoptive / methods*
  • Lymphoma, B-Cell / immunology
  • Lymphoma, B-Cell / pathology
  • Lymphoma, B-Cell / therapy*
  • Male
  • Neoplasm Grading
  • Treatment Outcome

Substances

  • Anti-Retroviral Agents
  • Antigens, CD19
  • Biological Products
  • axicabtagene ciloleucel